The "ITGA2B Gene Thrombocytopenia Neonatal Alloimmune Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the ITGA2B gene that can lead to neonatal alloimmune thrombocytopenia (NAIT). NAIT is a rare condition where the immune system of a pregnant individual produces antibodies against fetal platelets, leading to low platelet counts in the newborn, which can result in serious bleeding problems. The ITGA2B gene plays a crucial role in platelet aggregation and blood clotting, and mutations in this gene are one of the genetic factors that can contribute to the development of NAIT.
The test is particularly valuable for expectant parents with a history of NAIT in previous pregnancies or where there is a known genetic predisposition to thrombocytopenia. Early detection through this genetic test can help in the management and treatment of affected newborns, potentially preventing severe complications.
The cost of the "ITGA2B Gene Thrombocytopenia Neonatal Alloimmune Genetic Test" at DNA Labs UAE is 4400 AED. This investment in prenatal care can be crucial for the health and well-being of both the mother and the child, providing essential information for healthcare providers to prepare and intervene appropriately to manage this condition.
The ITGB3 gene thrombocytopenia neonatal alloimmune genetic test is a specialized diagnostic procedure designed to identify mutations in the ITGB3 gene, which can lead to neonatal alloimmune thrombocytopenia (NAIT). NAIT is a rare condition where a pregnant mother's immune system mistakenly targets the platelets of the fetus, leading to a low platelet count in the newborn, which can result in bleeding problems. This condition is of particular concern because it can cause serious health issues in affected newborns, including intracranial hemorrhage.
The test, available at DNA Labs UAE, involves analyzing the DNA of the fetus or newborn to detect any genetic variations in the ITGB3 gene that are known to contribute to the development of NAIT. This early detection is crucial for the timely management and treatment of the condition, potentially preventing its severe complications.
The cost of the ITGB3 gene thrombocytopenia neonatal alloimmune genetic test at DNA Labs UAE is 4400 AED. Given the specialized nature of the test and the significant implications of its results for affected families, it represents a critical investment in the health and well-being of the newborn. Families considering this test are advised to consult with a genetic counselor or a specialist in maternal-fetal medicine to fully understand the benefits, limitations, and potential outcomes of the testing process.
The "GATA1 Gene Thrombocytopenia X-Linked Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the GATA1 gene, which are associated with X-linked thrombocytopenia. Thrombocytopenia is a condition characterized by an abnormally low number of platelets in the blood, which can lead to increased bleeding and bruising. The GATA1 gene plays a crucial role in the development and function of blood cells, including platelets. Mutations in this gene can disrupt normal blood cell production and function, leading to various hematologic disorders, including thrombocytopenia.
This genetic test is particularly important for individuals with a family history of thrombocytopenia or related symptoms, as it can provide a definitive diagnosis of the condition being linked to a genetic cause. Early detection through genetic testing can enable appropriate management and treatment strategies to be implemented, potentially reducing the risk of complications associated with the condition.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. Upon completion, the results can provide valuable insights into the genetic underpinnings of thrombocytopenia in affected individuals, facilitating personalized medical care and informing family planning decisions.
The "WAS Gene Thrombocytopenia X-Linked Intermittent Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the WAS gene. This gene plays a crucial role in the immune system and cell signaling. Mutations in the WAS gene are associated with Wiskott-Aldrich Syndrome, a rare X-linked recessive disorder characterized by eczema, thrombocytopenia (low platelet count), immune deficiency, and an increased risk of autoimmune diseases and cancers. The test specifically targets individuals suspected of having intermittent expressions of the syndrome, providing crucial information for accurate diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it offers into the patient's genetic makeup, contributing to targeted treatment strategies and improved patient care.
The "JAK2 Gene Thrombocytosis Familial JAK2 Related Genetic Test" is a specialized diagnostic examination designed to detect mutations in the JAK2 gene, which are often associated with certain blood disorders, including familial thrombocytosis. Thrombocytosis is characterized by an abnormal increase in the number of platelets in the blood, which can lead to an increased risk of clotting or bleeding complications. The JAK2 gene plays a critical role in the signaling pathway that regulates blood cell production in the bone marrow. Mutations in this gene can lead to uncontrolled cell growth, resulting in conditions like thrombocytosis.
This genetic test is particularly crucial for individuals with a family history of thrombocytosis or related blood disorders, as it can help in the early diagnosis and management of the condition. By identifying the specific mutation in the JAK2 gene, healthcare providers can tailor treatment plans more effectively and offer genetic counseling for affected families.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is set at 4400 AED. DNA Labs UAE employs state-of-the-art technology and adheres to strict quality standards to ensure accurate and reliable test results. Patients opting for this test can expect a thorough analysis, with results that provide valuable insights into their genetic predisposition to thrombocytosis and related conditions.
The F2 Gene Thrombophilia due to Thrombin Defect Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting genetic mutations in the F2 gene. These mutations are associated with an increased risk of thrombophilia, a condition that predisposes individuals to forming abnormal blood clots. The F2 gene plays a critical role in the production of thrombin, a key enzyme in the blood clotting process. Mutations in this gene can lead to either an overactive or underactive clotting response, both of which can have significant health implications.
This test is crucial for individuals with a family history of thrombophilia or those who have experienced unexplained blood clotting events, as it can help in the early identification of genetic predispositions towards blood clot disorders. Early detection through this genetic testing allows for personalized medical management and preventive measures to reduce the risk of serious complications associated with thrombophilia, such as deep vein thrombosis, pulmonary embolism, and stroke.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the F2 Gene Thrombophilia due to Thrombin Defect Genetic Test is 4400 AED. This investment covers the collection of a DNA sample, usually through a blood draw, the laboratory analysis to identify any genetic mutations in the F2 gene, and a comprehensive report that outlines the findings and their implications for the individual's health. Patients considering this test are advised to consult with a healthcare professional to understand its benefits and implications fully.
The "F9 Gene Thrombophilia X-Linked Due to Factor IX Defect Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE. This test is designed to detect mutations in the F9 gene, which is responsible for producing Factor IX, a crucial protein for blood clotting. Thrombophilia due to a Factor IX defect is an X-linked condition, meaning it predominantly affects males, though female carriers may also experience symptoms. Mutations in the F9 gene can lead to either an increased risk of bleeding (hemophilia B) or, in rare cases, an increased risk of thrombosis.
At a cost of 4400 AED, the test provides a comprehensive analysis for individuals who have a family history of Factor IX deficiency or have experienced symptoms related to abnormal clotting. By identifying specific genetic alterations in the F9 gene, the test enables healthcare providers to tailor treatment and management plans to the individual's genetic profile, enhancing the effectiveness of therapy and preventive measures. Conducted at the state-of-the-art facilities of DNA Labs UAE, this genetic test is a critical tool for the accurate diagnosis and management of thrombophilia linked to the F9 gene defect.
The ADAMTS13 Gene Thrombotic Thrombocytopenic Purpura (TTP) Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ADAMTS13 gene. These mutations can lead to a rare, life-threatening disorder known as Thrombotic Thrombocytopenic Purpura. TTP is characterized by the formation of small blood clots throughout the body, leading to low platelet counts, red blood cell damage, and potentially severe organ damage if left untreated.
The test involves a detailed analysis of the ADAMTS13 gene to detect any genetic anomalies that could impair the production or function of the ADAMTS13 enzyme. This enzyme plays a crucial role in the regulation of blood clotting by breaking down von Willebrand factor, a large protein involved in clot formation. A deficiency or dysfunction of this enzyme due to genetic mutations can lead to the excessive clotting seen in TTP.
Offered at a cost of 4400 AED, the ADAMTS13 Genetic Test at DNA Labs UAE is a vital tool for the accurate diagnosis and management of TTP. It provides essential information that can guide treatment decisions, including the need for plasma exchange therapy or immunosuppressive treatments, and offers insights into the prognosis of the condition. This test is particularly important for individuals with a family history of TTP or those presenting with symptoms suggestive of the disorder, enabling timely and targeted interventions to prevent severe complications.
The TBXAS1 gene thromboxane synthase deficiency genetic test is a specialized diagnostic examination offered by DNA Labs UAE, aimed at detecting mutations in the TBXAS1 gene. Thromboxane synthase is an enzyme crucial for the synthesis of thromboxane A2, a compound that plays a vital role in platelet aggregation and blood vessel constriction. Deficiencies in this enzyme can lead to a variety of health issues, including bleeding disorders and cardiovascular problems.
This test is particularly important for individuals who have a family history of thromboxane synthase deficiency or who exhibit symptoms suggesting a potential deficiency. By analyzing a sample of the patient's DNA, the test identifies any genetic mutations in the TBXAS1 gene that may be responsible for reduced or absent enzyme activity.
The cost of the TBXAS1 gene thromboxane synthase deficiency genetic test at DNA Labs UAE is 4400 AED. This price includes the collection of the DNA sample, usually through a blood draw or cheek swab, and comprehensive analysis and reporting by the laboratory's genetic specialists. Results from this test can provide crucial information for the diagnosis, treatment, and management of conditions related to thromboxane synthase deficiency, guiding both patients and healthcare providers in making informed decisions about care and potential interventions.
The GGCX Gene Vitamin K-Dependent Clotting Factors Combined Deficiency Type 1 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the GGCX gene. These mutations can lead to a rare disorder known as Combined Deficiency of Vitamin K-Dependent Clotting Factors Type 1, which affects the body's ability to properly utilize vitamin K for blood clotting. This condition can result in a range of bleeding issues, from mild to severe.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed in the laboratory to detect any genetic anomalies in the GGCX gene that might impair the function of vitamin K-dependent proteins necessary for blood coagulation.
Identifying these genetic mutations can be crucial for the management and treatment of affected individuals, allowing for personalized treatment plans that can include vitamin K supplementation and other supportive therapies. The test is a vital tool for families with a history of bleeding disorders or for individuals showing symptoms related to vitamin K-dependent clotting factor deficiencies. Through early detection and intervention, patients can achieve a better quality of life and reduce the risk of serious bleeding complications.
